Microparticulate Formulations for the Controlled Release of Interleukin-2-Reference-Cited by-同舟云学术

Microparticulate Formulations for the Controlled Release of Interleukin-2

Published:2004-05 Issue:5 Volume:93 Page:1100-1109
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Thomas Tommy T.,Kohane Daniel S.,Wang Audrey,Langer Robert

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference59 articles.

1. Fundamental immunology;Paul,1999

2. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection. Correlation with its ability to block culture-induced down-modulation of Bcl-2;Adachi;J Immunol,1996

3. Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: A randomized, controlled, multicenter study;Carr;J Infect Dis,1998

4. Interleukin-2 increases CD4(+) lymphocyte numbers but does not enhance responses to immunization: Results of A5046s;Valdez;J Infect Dis,2003

5. Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer;Ratto;J Thoracic Cardiovasc Surg,1995

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Drug Release Rate of Implantable Matrices and Better Understanding of the Underlying Mechanisms through Experimental Design and Artificial Neural Network-Based Modelling;Pharmaceutics;2022-01-19

2. Controlled release of bioactive IL-2 from visible light photocured biodegradable elastomers for cancer immunotherapy applications;Pharmaceutical Development and Technology;2021-12-28

3. Cancer immunotherapy from biology to nanomedicine;Journal of Controlled Release;2021-08

4. Aliphatic Polyester‐Based Materials for Enhanced Cancer Immunotherapy;Macromolecular Bioscience;2021-04-28

5. Microparticles;Biomaterials Science;2020